Related Experiment Videos
Chemotherapy and radiotherapy. When to call it quits
1University of Queensland Centre for General Practice, Centre for Palliative Care Education and Research, Queensland, Australia. g.mitchell@sph.uq.edu.au
Australian Family Physician
|March 29, 2002
Summary
Deciding when to stop chemotherapy and radiotherapy for advanced cancer patients requires careful consideration of treatment benefits versus burdens. Patient goals, such as functional status and life events, should guide these critical treatment decisions.
Area of Science:
- Oncology
- Palliative Care
Background:
- Cancer patients often receive chemotherapy and radiotherapy with curative intent.
- Transitioning to palliative care necessitates re-evaluating treatment based on patient values and life goals.
Purpose of the Study:
- To explore the challenges in discontinuing chemotherapy and radiotherapy for advanced cancer patients.
- To emphasize the importance of aligning treatment goals with patient aspirations.
Main Methods:
- Discussion of the 'burden versus benefit' paradigm for treatment evaluation.
- Analysis of patient attitudes, beliefs, and life aims in treatment decisions.
Main Results:
- Treatment aims must align with patient-centered goals, often related to function or life events.
- Chemotherapy and radiotherapy can provide symptom relief and prolong life meaningfully in the palliative phase.
Conclusions:
- The decision to continue or cease cancer treatment requires a thorough 'burden versus benefit' assessment.
- Palliative chemotherapy and radiotherapy can be valuable when aligned with patient values and life objectives.